RAYMOND JAMES & ASSOCIATES - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$1,825,000
-65.8%
12,070
-67.0%
0.00%
-60.0%
Q2 2022$5,337,000
+15.8%
36,629
-5.8%
0.01%
+25.0%
Q1 2022$4,608,000
-8.9%
38,867
+5.9%
0.00%0.0%
Q4 2021$5,058,000
+84.8%
36,700
+86.2%
0.00%
+100.0%
Q3 2021$2,737,000
+42.3%
19,705
-0.6%
0.00%0.0%
Q2 2021$1,924,000
+50.9%
19,817
+6.2%
0.00%
+100.0%
Q1 2021$1,275,000
+26.6%
18,659
+58.8%
0.00%0.0%
Q4 2020$1,007,000
+27.8%
11,752
-3.0%
0.00%0.0%
Q3 2020$788,000
-4.0%
12,116
+7.9%
0.00%0.0%
Q2 2020$821,000
+113.2%
11,232
-0.7%
0.00%0.0%
Q1 2020$385,000
-24.7%
11,309
+20.4%
0.00%0.0%
Q4 2019$511,000
-10.4%
9,391
-31.3%
0.00%0.0%
Q3 2019$570,000
-6.1%
13,664
-1.4%
0.00%0.0%
Q2 2019$607,000
-31.6%
13,863
-19.7%
0.00%0.0%
Q1 2019$888,000
+40.3%
17,259
+0.9%
0.00%0.0%
Q4 2018$633,000
-2.8%
17,111
-1.4%
0.00%0.0%
Q3 2018$651,000
-6.2%
17,350
-1.3%
0.00%0.0%
Q2 2018$694,000
+53.2%
17,572
-0.2%
0.00%0.0%
Q1 2018$453,000
+1.8%
17,604
+6.6%
0.00%0.0%
Q4 2017$445,000
-24.4%
16,509
+4.8%
0.00%0.0%
Q3 2017$589,000
+49.9%
15,751
+0.3%
0.00%0.0%
Q2 2017$393,00015,7100.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2018
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$154,344,00072.03%
Knoll Capital Management, LLC 856,844$119,024,00059.36%
ORACLE INVESTMENT MANAGEMENT INC 2,124,055$295,053,00036.73%
ARS Investment Partners, LLC 466,668$64,825,0006.49%
KINGDON CAPITAL MANAGEMENT, L.L.C. 365,373$50,754,0006.18%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$24,490,0005.91%
SILVERARC CAPITAL MANAGEMENT, LLC 61,897$8,598,0004.86%
DAFNA Capital Management LLC 88,100$12,238,0003.25%
Avidity Partners Management LP 934,200$129,770,0002.88%
Eventide Asset Management 1,325,000$184,056,0002.43%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders